Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.13B |
| 2 |
AT&T
T
|
+$275M |
| 3 |
Apple
AAPL
|
+$248M |
| 4 |
Walt Disney
DIS
|
+$235M |
| 5 |
Nike
NKE
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.4B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.17B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$863M |
| 4 |
Advanced Micro Devices
AMD
|
+$808M |
| 5 |
Amazon
AMZN
|
+$783M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.82% |
| 2 | Technology | 1.6% |
| 3 | Consumer Discretionary | 1.3% |
| 4 | Financials | 0.99% |
| 5 | Communication Services | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
SS&C Technologies
SSNC
$19.6B
| $8.43M | ﹤0.01% |
102,883
-3,070
| -3% | -$236K |
|
|
SRNE
2927
CALL
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $8.43M | ﹤0.01% |
1,812,000
-169,400
| -9% | -$1.05M |
|
2928
Citi Trends
CTRN
$559M
| $8.43M | ﹤0.01% |
88,916
+68,975
| +346% | +$5.5M |
|
2929
NetApp
NTAP
$36.6B
| $8.42M | ﹤0.01% |
91,550
+7,305
| +9% | +$658K |
|
2930
PUT
Olin
OLN
$1.96B
| $8.41M | ﹤0.01% |
146,200
-39,700
| -21% | -$2.23M |
|
2931
CALL
WD-40
WDFC
$2.91B
| $8.39M | ﹤0.01% |
34,300
+26,200
| +323% | +$6.1M |
|
2932
CALL
iShares Preferred and Income Securities ETF
PFF
$13.1B
| $8.39M | ﹤0.01% |
212,700
+34,500
| +19% | +$1.34M |
|
2933
PUT
Bloomin' Brands
BLMN
$903M
| $8.37M | ﹤0.01% |
399,000
-65,600
| -14% | -$1.38M |
|
2934
State Street SPDR S&P Bank ETF
KBE
$1.7B
| $8.36M | ﹤0.01% |
153,295
-25,156
| -14% | -$1.39M |
|
2935
Atkore
ATKR
$3.16B
| $8.35M | ﹤0.01% |
75,120
-6,936
| -8% | -$705K |
|
2936
PUT
Barclays
BCS
$90.3B
| $8.35M | ﹤0.01% |
806,600
+47,500
| +6% | +$498K |
|
|
SOHU
2937
CALL
Sohu.com
SOHU
$369M
| $8.34M | ﹤0.01% |
512,500
+27,900
| +6% | +$526K |
|
2938
CALL
Children's Place
PLCE
$55.6M
| $8.34M | ﹤0.01% |
105,200
-4,500
| -4% | -$396K |
|
2939
Quanta Services
PWR
$90.7B
| $8.34M | ﹤0.01% |
72,744
-7,264
| -9% | -$838K |
|
2940
CALL
Direxion Daily Energy Bull 2X ETF
ERX
$255M
| $8.34M | ﹤0.01% |
281,300
-58,100
| -17% | -$1.77M |
|
2941
Zimmer Biomet
ZBH
$19.3B
| $8.33M | ﹤0.01% |
67,559
+20,303
| +43% | +$2.66M |
|
2942
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$431M
| $8.33M | ﹤0.01% |
68,557
+34,354
| +100% | +$4.31M |
|
|
VTLE
2943
CALL
DELISTED
Vital Energy
VTLE
| $8.32M | ﹤0.01% |
138,400
-54,700
| -28% | -$3.86M |
|
2944
PUT
Direxion Daily FTSE China Bull 3X ETF
YINN
$668M
| $8.32M | ﹤0.01% |
49,950
-5,345
| -10% | -$1.11M |
|
|
PLL
2945
CALL
DELISTED
Piedmont Lithium
PLL
| $8.32M | ﹤0.01% |
158,600
-174,200
| -52% | -$10.2M |
|
2946
PUT
Kulicke & Soffa
KLIC
$4.26B
| $8.32M | ﹤0.01% |
137,400
+36,300
| +36% | +$2.08M |
|
|
DEN
2947
CALL
DELISTED
Denbury Inc.
DEN
| $8.32M | ﹤0.01% |
108,600
-39,400
| -27% | -$3.12M |
|
2948
Louisiana-Pacific
LPX
$4.99B
| $8.32M | ﹤0.01% |
106,144
-67,028
| -39% | -$4.59M |
|
2949
CALL
California Resources
CRC
$4.63B
| $8.3M | ﹤0.01% |
194,400
+26,200
| +16% | +$1.12M |
|
2950
PUT
Brookfield
BN
$92.1B
| $8.3M | ﹤0.01% |
255,131
-31,544
| -11% | -$998K |
|
Similar funds
Jeff Yass's Q4 2021 Portfolio in Review
As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
- Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
- Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
- Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
- Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
- Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
- Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.
Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.